DE69226370T2 - Parathyroidhormon enthaltene emulsion zur nasalen verabreichung - Google Patents
Parathyroidhormon enthaltene emulsion zur nasalen verabreichungInfo
- Publication number
- DE69226370T2 DE69226370T2 DE69226370T DE69226370T DE69226370T2 DE 69226370 T2 DE69226370 T2 DE 69226370T2 DE 69226370 T DE69226370 T DE 69226370T DE 69226370 T DE69226370 T DE 69226370T DE 69226370 T2 DE69226370 T2 DE 69226370T2
- Authority
- DE
- Germany
- Prior art keywords
- parathyroidhormone
- nasal administration
- emulsion
- integer
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000003982 Parathyroid hormone Human genes 0.000 title abstract 2
- 108090000445 Parathyroid hormone Proteins 0.000 title abstract 2
- 239000000839 emulsion Substances 0.000 title abstract 2
- 239000000199 parathyroid hormone Substances 0.000 title abstract 2
- 229960001319 parathyroid hormone Drugs 0.000 title abstract 2
- 125000006538 C11 alkyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000003976 azacycloalkanes Chemical class 0.000 abstract 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 abstract 1
- 229960004949 glycyrrhizic acid Drugs 0.000 abstract 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 abstract 1
- 239000001685 glycyrrhizic acid Substances 0.000 abstract 1
- 235000019410 glycyrrhizin Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Otolaryngology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP03236193A JP3090353B2 (ja) | 1991-09-17 | 1991-09-17 | パラチロイドホルモン類含有経鼻投与用乳剤 |
| PCT/JP1992/001179 WO1993005805A1 (en) | 1991-09-17 | 1992-09-16 | Emulsion containing parathyroid hormone for pernasal administration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69226370D1 DE69226370D1 (de) | 1998-08-27 |
| DE69226370T2 true DE69226370T2 (de) | 1999-04-22 |
Family
ID=16997158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69226370T Expired - Fee Related DE69226370T2 (de) | 1991-09-17 | 1992-09-16 | Parathyroidhormon enthaltene emulsion zur nasalen verabreichung |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5407911A (de) |
| EP (1) | EP0610502B1 (de) |
| JP (1) | JP3090353B2 (de) |
| KR (1) | KR0129865B1 (de) |
| AT (1) | ATE168562T1 (de) |
| AU (1) | AU662168B2 (de) |
| CA (1) | CA2118655C (de) |
| DE (1) | DE69226370T2 (de) |
| WO (1) | WO1993005805A1 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1255723B (it) * | 1992-10-09 | 1995-11-13 | Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione | |
| AU686149B2 (en) * | 1993-04-19 | 1998-02-05 | Institute For Advanced Skin Research Inc. | Microemulsion preparation containing difficultly absorbable substance |
| CA2145302C (en) * | 1993-07-30 | 2008-10-28 | Masahiko Dohi | Peptide proteinaceous drug nasal powder composition |
| US5496801A (en) * | 1993-12-23 | 1996-03-05 | Allelix Biopharmaceuticals Inc. | Parathyroid hormone formulation |
| US6379688B2 (en) | 1997-02-28 | 2002-04-30 | Senju Pharmaceutical Co., Ltd. | Preservative for emulsion and emulsion containing same |
| JP2000247911A (ja) * | 1999-02-26 | 2000-09-12 | Hisamitsu Pharmaceut Co Inc | 大腸用吸収促進剤 |
| US8580290B2 (en) * | 2001-05-08 | 2013-11-12 | The Board Of Regents Of The University Of Oklahoma | Heparosan-based biomaterials and coatings and methods of production and use thereof |
| WO2003039331A2 (en) * | 2001-11-05 | 2003-05-15 | Eli Lilly And Company | Method for improving stability of a bone-connecting implant |
| EP1380630A3 (de) * | 2002-07-11 | 2004-01-28 | Herbal Apothecary Limited | Netz- und Trennungsmittel für Kohlenwasserstoffe. |
| US7329725B1 (en) * | 2003-10-29 | 2008-02-12 | Nastech Pharmaceutical Company Inc. | Phage displayed Trp cage ligands |
| US20060189533A1 (en) * | 2004-05-10 | 2006-08-24 | Nastech Pharmaceutical Company Inc. | Stable pharmaceutical dosage forms of teriparatide |
| US20060052306A1 (en) * | 2004-05-10 | 2006-03-09 | Nastech Pharmaceutical Company Inc. | GRAS composition for enhanced mucosal delivery of parathyroid hormone |
| US20070173447A1 (en) * | 2005-10-25 | 2007-07-26 | Nastech Pharmaceutical Company Inc. | Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agent |
| US20080051332A1 (en) * | 2005-11-18 | 2008-02-28 | Nastech Pharmaceutical Company Inc. | Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone |
| US20080119408A1 (en) * | 2006-07-07 | 2008-05-22 | Nastech Pharmaceutical Company Inc. | Pth formulations for intranasal delivery |
| EP1961765A1 (de) * | 2006-12-08 | 2008-08-27 | Zealand Pharma A/S | Verkürzte PTH-Peptide mit zyklischer Konformation |
| US9687559B2 (en) * | 2008-03-19 | 2017-06-27 | The Board Of Regents Of The University Of Oklahoma | Heparosan polymers and methods of making and using same for the enhancement of therapeutics |
| US9925209B2 (en) | 2008-03-19 | 2018-03-27 | The Board Of Regents Of The University Of Oklahoma | Heparosan-polypeptide and heparosan-polynucleotide drug conjugates and methods of making and using same |
| PL2831237T3 (pl) | 2012-03-30 | 2018-06-29 | The Board Of Regents Of The University Of Oklahoma | Polimery heparosanu o wysokiej masie cząsteczkowej i sposoby ich wytwarzania i zastosowania |
| CN111447943A (zh) * | 2018-10-29 | 2020-07-24 | 旭化成制药株式会社 | 以按每周2次的频率给予特立帕肽或其盐为特征的骨质疏松症的预防或治疗方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1248450A (en) * | 1984-04-05 | 1989-01-10 | Kazuo Kigasawa | Soft patch |
| JPH0643390B2 (ja) * | 1986-04-08 | 1994-06-08 | 久光製薬株式会社 | アザシクロアルカン誘導体 |
| US5059587A (en) * | 1987-08-03 | 1991-10-22 | Toyo Jozo Company, Ltd. | Physiologically active peptide composition for nasal administration |
| JPH01233230A (ja) * | 1988-03-14 | 1989-09-19 | Minofuaagen Seiyaku Honpo:Goushi | 経粘膜吸収促進剤及びこれを用いた点鼻剤 |
| JP2720899B2 (ja) * | 1988-07-15 | 1998-03-04 | 合資会社ミノファーゲン製薬本舗 | 経粘膜吸収促進剤及びこれを用いた経鼻投与剤 |
| JP2911496B2 (ja) * | 1989-09-11 | 1999-06-23 | 帝國製薬株式会社 | 生理活性ポリペプチド含有高吸収性経膣剤 |
| JPH0446129A (ja) * | 1990-06-12 | 1992-02-17 | Asahi Chem Ind Co Ltd | 新規なリポソーム形成助剤 |
| JPH078806B2 (ja) * | 1990-08-16 | 1995-02-01 | 旭化成工業株式会社 | カルシトニン類含有経鼻投与用乳剤 |
| GB9020544D0 (en) * | 1990-09-20 | 1990-10-31 | Sandoz Ltd | Improvements in or relating to organic compounds |
-
1991
- 1991-09-17 JP JP03236193A patent/JP3090353B2/ja not_active Expired - Lifetime
-
1992
- 1992-09-16 KR KR1019940700867A patent/KR0129865B1/ko not_active IP Right Cessation
- 1992-09-16 DE DE69226370T patent/DE69226370T2/de not_active Expired - Fee Related
- 1992-09-16 AU AU25843/92A patent/AU662168B2/en not_active Ceased
- 1992-09-16 US US08/211,035 patent/US5407911A/en not_active Expired - Lifetime
- 1992-09-16 AT AT92919966T patent/ATE168562T1/de not_active IP Right Cessation
- 1992-09-16 WO PCT/JP1992/001179 patent/WO1993005805A1/ja active IP Right Grant
- 1992-09-16 EP EP92919966A patent/EP0610502B1/de not_active Expired - Lifetime
- 1992-09-16 CA CA002118655A patent/CA2118655C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2584392A (en) | 1993-04-27 |
| CA2118655C (en) | 1997-08-19 |
| DE69226370D1 (de) | 1998-08-27 |
| CA2118655A1 (en) | 1993-04-01 |
| AU662168B2 (en) | 1995-08-24 |
| WO1993005805A1 (en) | 1993-04-01 |
| EP0610502B1 (de) | 1998-07-22 |
| ATE168562T1 (de) | 1998-08-15 |
| JPH0570367A (ja) | 1993-03-23 |
| JP3090353B2 (ja) | 2000-09-18 |
| US5407911A (en) | 1995-04-18 |
| EP0610502A4 (de) | 1996-02-28 |
| KR0129865B1 (ko) | 1998-04-09 |
| EP0610502A1 (de) | 1994-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69226370T2 (de) | Parathyroidhormon enthaltene emulsion zur nasalen verabreichung | |
| MX9304300A (es) | Composiciones herbicidas. | |
| KR890016966A (ko) | 신규 항바이러스제 | |
| BR9306399A (pt) | Composição farmacéutica para uso no tratamento de glaucoma | |
| ES8802420A1 (es) | Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico | |
| IE790652L (en) | Imidazole derivatives | |
| ES2014385A4 (es) | Composicion antimicrobiana. | |
| KR950000663A (ko) | 트리테르펜 유도체 및 이를 함유하는 엔도텔린-수용체 길항물질 | |
| DE69100436D1 (de) | Kalzitonin enthaltende emulsion zur nasalen verabreichung. | |
| ATE168008T1 (de) | Sparfloxacin-salze und sie enthaltende lösungen | |
| MX9200777A (es) | 4-[(2-benzotiazolil)metilamino]-alfa-[(3,4-difluorofenoxi)metil]-1-pip eridetanol. | |
| MX9206930A (es) | Nuevos compuestos | |
| DK390384A (da) | Midler med antimikrobiel virkning indeholdende derivater af benzoesyre og deres anvendelse som desinficerende laegemidler eller konserveringsmidler | |
| KR950032194A (ko) | 신규푸린유도체 및 그 약학적으로 허용되는 염 | |
| DK0548635T3 (da) | Farmaceutisk præparat af Roxindol eller Carmoxirol med foropkvældet stivelse | |
| KR900701262A (ko) | 췌장염 등에 대한 치료제 | |
| HUT48259A (en) | Herbicide compositions containing new macrolide active components, and process for producing new macrolide compounds and pharmaceutical compositions containing them as active components | |
| FR2674436B1 (fr) | Nouvelle utilisation de sterouides 4,9,11-trieniques dans des compositions destinees a l'administration chez la dinde. | |
| AU560610B2 (en) | Iodophor disinfectants | |
| AU629667B2 (en) | Insecticide compositions containing as active ingredient glufosinate or one of its salts | |
| DK551487A (da) | 1-hydroxyalkylxanthiner samt farmaceutiske praeparater med indhold af saadanne forbindelser | |
| KR920019734A (ko) | 페닐술포닐알칸산 화합물 | |
| KR860002498A (ko) | 1,4-디하이드로피리딘 유도체의 약학조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: ASAHI KASEI PHARMA CORP., TOKIO/TOKYO, JP Owner name: HISAMITSU SEIYAKU K.K., TOSU, SAGA, JP |
|
| 8328 | Change in the person/name/address of the agent |
Representative=s name: BOETERS & LIECK, 81541 MUENCHEN |
|
| 8339 | Ceased/non-payment of the annual fee |